Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium
Go back to Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium| Genentech, Inc. (NYSE: DNA) | Delayed: 10.01 +0.15 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.86 | 52 Week High | $99.14 | |||
| Open | $9.88 | 52 Week Low | $69.17 | |||
| Day High | $10.10 | P/E | 3.12 | |||
| Day Low | $9.61 | EPS | $3.21 | |||
| Volume | 1,767,486 | |||||



